Etablissementen Franz Colruyt NV (0N4Y)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 36.88 |
|---|---|
| 52-week range | 30.16 – 40.00 |
| Return, 1 month / 3 months | −5.0% / −3.2% |
| Return, 1 year / 3 years | +12.0% / +0.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 53 |
| Volatility (1 year) | 22.3% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 0.20M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Etablissementen Franz Colruyt is a Belgian retail group based in Halle that runs a family of store formats. Its main business is Colruyt discount supermarkets, which offer everyday groceries at low prices to households in Belgium and neighbouring countries. The group also operates OKay convenience stores, Bio-Planet organic supermarkets, DreamLand toy shops and the Collect&Go online grocery ordering and pickup service, serving shoppers through both physical stores and digital channels.
On this site Etablissementen Franz Colruyt NV appears as a stock on the London Exchange (UK), code 0N4Y, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Etablissementen Franz Colruyt NV (0N4Y) trades on the London Exchange in UK. It last closed at EUR 36.88 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 921 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.0% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.8% | ||
| From 52-week high | -7.2% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | 10.6% | ||
| 12-month return, skipping the last month | 17.9% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.20M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.8% |
|---|---|
| 1 month | −5.0% |
| 3 months | −3.2% |
| 6 months | +10.6% |
| 1 year | +12.0% |
| 3 years | +0.1% |
| 5 years | −1.6% |
Signals
| 50-day / 200-day average | 37.68 / 35.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Sep 2025 | EUR 0.9660 |
| 27 Sep 2024 | EUR 0.9660 |
| 20 Dec 2023 | EUR 0.7000 |
| 29 Sep 2023 | EUR 0.5600 |
| 30 Sep 2022 | EUR 0.7700 |
| 1 Oct 2021 | EUR 1.0290 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.